Clinical Trial Update: Terlipressin in Septic Shock in Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates completion of Phase 2 and Phase 3 studies evaluating terlipressin for septic shock in patients with liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Septic Shock

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Liver Cirrhosis, Septic Shock | Phase 2, Phase 3 | Status: COMPLETED